769517657	769517657	CD	B-NP	O
|	|	NN	I-NP	O
EOMC	EOMC	NN	I-NP	O
|	|	NN	I-NP	O
80056013	80056013	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5677112	5677112	CD	B-NP	O
|	|	CC	I-NP	O
10/21/2006	10/21/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
r/o	r/o	NN	I-NP	O
aCUTE	aCUTE	NNP	I-NP	O
CORORNARY	CORORNARY	NNP	I-NP	O
SYNDROME	SYNDROME	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/21/2006	10/21/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/10/2006	4/10/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
LANGILL	LANGILL	NN	B-NP	O
,	,	,	O	O
ADOLPH	ADOLPH	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Renal	Renal	NNP	I-NP	O
Transplant	Transplant	NNP	I-NP	O
PA	PA	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

ADMITTING	ADMITTING	VBG	B-VP	O
DIAGNOSES	DIAGNOSES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
renal	renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
requiring	require	VBG	B-VP	O
dialysis	dialysis	NN	B-NP	O
initiation	initiation	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
-	-	HYPH	O	O
improved	improve	VBN	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
failed	fail	VBD	B-VP	O
renal	renal	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
AND	AND	CC	I-NP	O
CONDITIONS	CONDITIONS	NNS	I-NP	O
AFFECTING	AFFECTING	VBG	B-VP	O
TREATMENT	TREATMENT	NN	B-NP	O
OR	OR	NN	I-NP	O
STAY	STAY	NN	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
,	,	,	O	O
CVA	CVA	NN	B-NP	B-protein
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURE	PROCEDURE	NN	I-NP	O
:	:	:	O	O
Not	Not	RB	B-ADJP	O
applicable	applicable	JJ	I-ADJP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
TREATMENTS	TREATMENTS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Initiation	Initiation	NN	B-NP	O
of	of	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
diuretics	diuretic	NNS	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
SUMMARY	SUMMARY	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Berliew	Berliew	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
living	live	VBG	B-VP	O
related	related	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
delayed	delay	VBN	B-NP	O
graft	graft	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
ATN	ATN	NN	I-NP	O
and	and	CC	I-NP	O
CVA	CVA	NN	I-NP	B-protein
with	with	IN	B-PP	O
resultant	resultant	JJ	B-NP	O
hemiplegia	hemiplegia	NN	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
reexplorations	reexploration	NNS	I-NP	O
of	of	IN	B-PP	O
transplant	transplant	NN	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
transplant	transplant	NN	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
renal	renal	JJ	I-NP	O
biopsies	biopsy	NNS	I-NP	O
for	for	IN	B-PP	O
delayed	delay	VBN	B-NP	O
graft	graft	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADJP	O
recent	recent	JJ	I-ADJP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2006	2006	CD	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
ATN	ATN	NN	B-NP	B-protein
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Straathof	Straathof	NNP	I-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
from	from	IN	B-PP	O
Rehab	Rehab	NN	B-NP	B-protein
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
arrival	arrival	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
moderate	moderate	JJ	B-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
BNP	BNP	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x2	x2	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	O	O
nitro	nitro	NN	B-NP	O
paste	paste	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
0.17	0.17	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
BP	BP	NN	I-NP	O
upon	upon	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	B-DNA
was	be	VBD	B-VP	I-DNA
195/86	195/86	CD	B-NP	I-DNA
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
3.6	3.6	CD	B-NP	O
and	and	CC	O	O
potassium	potassium	NN	B-NP	O
4.8	4.8	CD	I-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Umlauf	Umlauf	NNP	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
several	several	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
complaints	complaint	NNS	I-NP	O
and	and	CC	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
Rehab	Rehab	NNP	I-NP	O
Facility	Facility	NN	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
okay	okay	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
without	without	IN	B-PP	O
much	much	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
functional	functional	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
persistently	persistently	RB	B-ADVP	O
complains	complain	VBZ	B-VP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
coccyx	coccyx	NN	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
voiding	void	VBG	I-VP	O
regularly	regularly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
pruritus	pruritus	NN	I-NP	O
or	or	CC	I-NP	O
metallic	metallic	JJ	I-NP	O
taste	taste	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

Reports	Report	NNS	B-NP	O
good	good	JJ	I-NP	O
appetite	appetite	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
As	As	IN	B-PP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
in	in	IN	B-PP	O
detail	detail	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
ESRD	ESRD	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
diabetes	diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
living	live	VBG	B-VP	O
related	relate	VBN	B-NP	O
transplant	transplant	NN	I-NP	B-protein
10/27/05	10/27/05	CD	I-NP	I-protein
,	,	,	O	O
CKD	CKD	NN	B-NP	B-protein
baseline	baseline	NN	I-NP	I-protein
creatinine	creatinine	NN	I-NP	I-protein
about	about	IN	B-PP	I-protein
2.5	2.5	CD	B-NP	I-protein
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
x3	x3	NN	I-NP	I-protein
including	include	VBG	B-PP	O
one	one	CD	B-NP	O
posttransplant	posttransplant	NN	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
dense	dense	JJ	B-NP	O
left	left	JJ	I-NP	O
hemiplegia	hemiplegia	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
transthoracic	transthoracic	JJ	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
2006	2006	CD	I-NP	O
,	,	,	O	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
lumbar	lumbar	NN	B-NP	O
fracture	fracture	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
fusion	fusion	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NNP	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
lower	low	JJR	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
off	off	IN	B-PP	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
,	,	,	O	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
BPH	BPH	NN	B-NP	B-protein
with	with	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
retention	retention	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
include	include	VBP	B-VP	O
CellCept	CellCept	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Decadron	Decadron	NNP	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Bactrim	Bactrim	NNP	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
labetolol	labetolol	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Aranesp	Aranesp	IN	B-NP	O
40	40	CD	I-NP	O
mcg	mcg	NN	I-NP	O
subcu	subcu	NN	I-NP	O
every	every	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
324	324	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcu	subcu	NN	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
,	,	,	O	O
Aspart	Aspart	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Remeron	Remeron	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Xanax	Xanax	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
5/325	5/325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
97.2	97.2	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
61	61	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
172/80	172/80	CD	I-NP	I-DNA
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
20	20	CD	B-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Generally	Generally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
well-developed	well-developed	JJ	I-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
white	white	JJ	I-NP	O
male	male	NN	I-NP	O
in	in	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
,	,	,	O	O
normocephalic	normocephalic	JJ	B-ADJP	O
,	,	,	O	O
EOMI	EOMI	NNP	B-NP	O
.	.	.	O	O

PERRLA	PERRLA	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

Heart	Heart	RB	B-ADVP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
,	,	,	I-NP	O
split	split	JJ	I-NP	O
S2	S2	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
and	and	CC	I-NP	O
mildly	mildly	RB	I-NP	O
distended	distended	JJ	I-NP	O
,	,	,	I-NP	O
normoactive	normoactive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
allograft	allograft	NN	B-NP	O
nontender	nontender	NN	I-NP	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
stage	stage	NN	B-NP	O
2	2	CD	I-NP	O
coccyx	coccyx	NN	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	RB	B-ADVP	O
,	,	,	O	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tremor	tremor	NN	I-NP	O
.	.	.	O	O

Mood	Mood	NN	B-NP	O
okay	okay	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Creatinine	Creatinine	NN	B-NP	O
elevated	elevate	VBD	B-VP	O
to	to	TO	B-PP	O
4.0	4.0	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
exhibiting	exhibit	VBG	B-VP	O
uremic	uremic	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
9/12/06	9/12/06	CD	B-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
his	his	PRP$	B-NP	O
uremic	uremic	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
his	his	PRP$	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
for	for	IN	B-PP	O
access	access	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
functioning	function	VBG	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Immunosuppression	Immunosuppression	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
CellCept	CellCept	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
250	250	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
graft	graft	NN	B-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admiited	admiite	VBN	I-VP	O
with	with	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypovolemia	hypovolemia	NN	B-NP	O
.	.	.	O	O

BP	BP	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
fairly	fairly	RB	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

Volume	Volume	NN	B-NP	O
status	status	NN	I-NP	O
-	-	HYPH	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
dialysis	dialysis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
metolazone	metolazone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
using	use	VBG	I-VP	O
an	an	DT	B-NP	O
air	air	NN	I-NP	O
mattress	mattress	NN	I-NP	O
to	to	TO	B-VP	O
alleviate	alleviate	VB	I-VP	O
pressure	pressure	NN	B-NP	O
sores	sore	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
patch	patch	NN	I-NP	O
0.25	0.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
q.	q.	NN	I-NP	O
72	72	CD	B-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
hold	hold	VBP	B-VP	O
both	both	CC	B-PP	O
for	for	IN	I-PP	O
sedation	sedation	NN	B-NP	O
.	.	.	O	O

Fluid	Fluid	NN	B-NP	O
and	and	CC	I-NP	O
Electrolytes	Electrolyte	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
1	1	CD	I-NP	O
liter	liter	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
,	,	,	O	O
strict	strict	JJ	B-NP	O
Is	Is	NNS	I-NP	O
and	and	CC	I-NP	O
Os	O	NNS	I-NP	O
,	,	,	O	O
daily	daily	JJ	B-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
trazodone	trazodone	NN	B-NP	O
,	,	,	O	O
Remeron	Remeron	NN	B-NP	O
,	,	,	O	O
Xanax	Xanax	NN	B-NP	O
and	and	CC	I-NP	O
Zyprexa	Zyprexa	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

Hold	Hold	NN	B-NP	O
if	if	IN	B-SBAR	O
sedated	sedate	VBN	B-VP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Haroun	Haroun	NNP	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
Services	Service	NNS	I-NP	O
today	today	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
call	call	VB	I-VP	O
the	the	DT	B-NP	O
Renal	Renal	JJ	I-NP	B-cell_line
Transplant	Transplant	NN	I-NP	I-cell_line
Nursing	Nurse	VBG	B-VP	I-cell_line
Line	Line	NN	B-NP	I-cell_line
at	at	IN	B-PP	O
763-461-6525	763-461-6525	CD	B-NP	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
any	any	DT	B-NP	O
questions	question	NNS	I-NP	O
or	or	CC	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
instructed	instruct	VBN	I-VP	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
emergency	emergency	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
weekend	weekend	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
fellow	fellow	JJ	I-NP	O
on-call	on-call	JJ	I-NP	O
paged	page	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
any	any	DT	B-NP	O
worsening	worsen	VBG	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
or	or	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Xanax	Xanax	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
acetate	acetate	NN	I-NP	O
667	667	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Decadron	Decadron	NNP	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Fentanyl	Fentanyl	NN	B-NP	O
25	25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
transdermal	transdermal	JJ	B-ADJP	O
,	,	,	O	O
q.	q.	NN	B-NP	B-protein
72	72	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
Human	Human	JJ	I-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Labetalol	Labetalol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Metolazone	Metolazone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Miconazole	Miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Remeron	Remeron	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

CellCept	CellCept	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Nephrocaps	Nephrocaps	RB	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Zyprexa	Zyprexa	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
12	12	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
sedated	sedate	VBD	B-VP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

Trazodone	Trazodone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Bactrim	Bactrim	JJ	B-NP	O
single	single	JJ	I-NP	O
strength	strength	NN	I-NP	O
one	one	CD	B-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-7406660	9-7406660	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
RANMAR	RANMAR	NN	B-NP	B-protein
,	,	,	O	O
RICARDO	RICARDO	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MICKONIS	MICKONIS	NNP	B-NP	O
,	,	,	O	O
BRETT	BRETT	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1336248	1336248	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/4/06	8/4/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/4/06	8/4/06	CD	B-NP	O

